Acarix AB (publ) (FRA:7AC)

Market Cap	28.14M +22.1%
Revenue (ttm)	625.83K +21.9%
Net Income	-4.74M
EPS	-0.00
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	325
Open	0.0190
Previous Close	0.0190
Day's Range	0.0190 - 0.0190
52-Week Range	0.0112 - 0.0448
Beta	n/a
RSI	35.56
Earnings Date	Feb 12, 2026

About Acarix AB

Acarix AB (publ), a medical device company, develops solutions for rapid AI-based coronary artery disease rule-out. The company offers CADScor System, a point-of-care diagnostic aid that uses sensitive acoustics and advanced computational processing to analyze the patient's coronary blood flow. It sells its products in the Nordic countries, the United Kingdom, Germany, Switzerland, Austria, Mauritius, and the United States. The company was founded in 2009 and is headquartered in Malmö, Sweden.

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2009
• Employees: 8
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 7AC

Financial Performance

In 2024, Acarix AB's revenue was 6.20 million, a decrease of -0.62% compared to the previous year's 6.24 million. Losses were -66.19 million, -14.97% less than in 2023.

Financial numbers in SEK